{"title": "Inovio Biomedical Completes Enrollment of Cervical Cancer Therapeutic Vaccine Study", "author": null, "url": "https://www.fiercebiotech.com/biotech/inovio-biomedical-completes-enrollment-of-cervical-cancer-therapeutic-vaccine-study", "hostname": "fiercebiotech.com", "description": "Significant antigen-specific T-cell and antibody responses shown in low and medium dose groups BLUE BELL, Pa.--(BUSINESS WIRE)-- Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA | Significant antigen-specific T-cell and antibody responses shown in low and medium dose groups BLUE BELL, Pa.--(BUSINESS WIRE)-- Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA", "sitename": "FierceBiotech", "date": "2010-04-08", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}